Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2007 Vol. 4
p
 
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 4
Nanotech 2007 Vol. 4
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 4
 
Chapter 2: Nanoparticles
 

Nano-Biotechnology toward Diagnostic Industry: Obstacles and Opportunities

Authors:H. Esfandyarpour
Affilation:Stanford, US
Pages:422 - 425
Keywords:nanobiosensor, diagnostics, infectious disease detector, nanobiotechnology, AIDS, nanotubes, nanowires, nanocrystals, quantum dots, HIV
Abstract:Biosensing of infectious agents should be ideally real-time, multiplexed, sensitive and specific. While no single device thus far have demonstrated superiority with respect to all these qualities, many of the upcoming nanomaterial-based sensors described in this paper appear to be promising and could potentially deliver real-time, multiplexed detections while achieving similar if not better sensitivity and specificity than conventional methods. Here we chart recent advances in the state-of-the-art nano-methods which are being used to fill this need in biotechnology and look at the different challenges and possibilities through the industrialization in the future of these technologies in the real world. In terms of device evaluation, more clinically relevant samples (e.g. body fluids, sputum and stools) should be used instead of purified samples, which are not always available. This is because the blood might contain hemoglobin that could interfere with light emission from quantum dots and if acidic could affect antibody-pathogen binding on either nanowires or nanotubes. High ionic strength of serum could also potentially hinder electrical detection by nanowires. For the detection of biothreat agents, only a handful of devices and no nanodevices yet have been tested under field conditions, which should be the ultimate if not most clinically relevant test. This is important because sample collection, sample matrix processing, and environmental conditions could all affect the performance of biosensors.
Nano-Biotechnology toward Diagnostic Industry: Obstacles and OpportunitiesView paper
ISBN:1-4200-6376-6
Pages:768
Hardcopy:$199.99
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
Upcoming Events
Nanotech 2009
Cleantech 2009
BioNano 2009
TechConnect Summit
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact